Baseline characteristics of the enrolled patients with coronary artery aneurysm (N=458)
| Medical (N=230) | CABG (N=176) | PCI (N=52) | P value | |
| Age (years), mean±SD | 77.7±10.3 | 79.7±10.1 | 74.1±11.4 | 0.002 |
| Gender (males) | 168 (73) | 133 (75.6) | 40 (77) | 0.77 |
| Hypertension | 167 (72.6) | 151 (85.8) | 35 (67.3) | 0.001 |
| Diabetes | 68 (29.6) | 56 (31.8) | 12 (23.1) | 0.46 |
| Coronary artery disease | 185 (80.4) | 156 (88.6) | 47 (90.4) | 0.02 |
| Hyperlipidaemia | 173 (75.2) | 154 (87.5) | 41 (78.8) | 0.04 |
| Chronic kidney disease | 38 (16.5) | 25 (14.2) | 5 (9.6) | 0.44 |
| Congestive heart failure | 78 (33.9) | 53 (30.1) | 18 (34.6) | 0.70 |
| Anginal symptoms | 129 (56.1) | 122 (69.3) | 42 (80.7) | 0.001 |
| H/O smoking | 140 (60.8) | 84 (47.7) | 26 (50) | 0.03 |
| Aortic aneurysm | 16 (7) | 14 (8) | 13 (25) | 0.66 |
| Peripheral vascular disease | 21 (9.1) | 25 (14.2) | 9 (17.3) | 0.13 |
| Warfarin use | 41 (17.8) | 28 (15.9) | 6 (11.5) | 0.54 |
| DAPT use | 65 (28.3) | 34 (19.3) | 41 (78.8) | <0.001 |
| SYNTAX scores (mean±SD) | 6.5±8.2 | 15.4±8.4 | 10.3±5.7 | <0.001 |
| Aneurysm size (mean±SD) | 0.6±0.34 | 0.6±0.22 | 0.69±0.17 | 0.64 |
| Aneurysm/vessel ratio (mean±SD) | 2.28±1.4 | 2.26±0.67 | 1.77±0.44 | 0.35 |
Data are frequency (%) unless otherwise stated. Bold font indicates statistical significance (p<0.05).
CABG, coronary artery bypass grafting; DAPT, dual antiplatelet therapy; PCI, percutaneous coronary intervention.